ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676558 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676558; 2) Community: the network communities that were significantly associated with the response to NSC 676558; 3) Molecule: the relationships between components within communities and NSC 676558; 4) MDR: the compounds that were significantly associated with the NSC 676558.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0273071169565318 0.081553879
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.0273071169565318 -0.15661856
NSC 205862 Null 0.0273071169565318 -0.21665313
NSC 281383 Null 0.0273071169565318 0.13848641
NSC 305780 Ethanol, compd. with 6-(2-naphthalenylthio)-2,4-quinazolinediamine (1:2) 0.0273071169565318 0.035778765
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0273071169565318 0.0094420422
NSC 36768 Null 0.0273071169565318 0.26530759
NSC 606498 Camptothecin Derivative 0.0273071169565318 0.077345999
NSC 609699 Topotecan hydrochloride 0.0273071169565318 0.054355477
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0273071169565318 0.32017118
Total:76  Current:41    [First] [Prev] [Next] [Last]